Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2000
10/26/2000CA2330231A1 Composition and method for modulating dendritic cell-t cell interaction
10/25/2000EP1047108A2 A method of determining peptide sequences by mass spectrometry
10/25/2000EP1047107A2 Improved methods of identifying peptides and protein by mass spectrometry
10/25/2000EP1046914A1 Method and reagents for the determination of bilirubins
10/25/2000EP1046913A2 Immunochromatographic assay
10/25/2000EP1046912A1 Device and methods for determination of analyte in a solution
10/25/2000EP1046911A1 Methods for identification of proteinaceous substances capable of inducing cellular reactions
10/25/2000EP1046910A2 Apparatus for measuring gaseous components in breath and a cellular phone equipped with the function of measuring gaseous components
10/25/2000EP1046909A1 Method and apparatus for determining the Joule-Thomson coefficient of a fluid
10/25/2000EP1046908A2 Method for measuring the condition of oils and fats
10/25/2000EP1046906A2 Gas sensor
10/25/2000EP1046905A1 Method and device for measuring composition and concentration of biomass
10/25/2000EP1046902A2 Apparatus and method for evaluating quality of granular objects
10/25/2000EP1046899A2 Method and apparatus for determining the true stress and true strain behaviour of a ductile polymer
10/25/2000EP1046898A2 Automatic stainer for staining objects for microscopic examination
10/25/2000EP1046895A2 Panel testing apparatus and method
10/25/2000EP1046716A1 Methods for quantitating high-density lipoprotein cholesterol
10/25/2000EP1046714A2 A method and kit for measuring mitochondrial activity
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046651A1 Composition and method for modulating dendritic cell-T interaction
10/25/2000EP1046649A1 Solid phase nucleic acid labeling by transamination
10/25/2000EP1046402A1 Aged skin equivalent, methods of preparation and uses thereof
10/25/2000EP1046401A2 Fatty acid derivative labelled with a radioactive transition metal
10/25/2000EP1046122A1 Methods for monitoring the status of assays
10/25/2000EP1046038A1 Use of mass fingerprinting for identification of protein affinity ligands
10/25/2000EP1046037A1 Improved magnetic particles, method for obtaining same and uses for separating molecules
10/25/2000EP1046035A2 A device for testing liquids
10/25/2000EP1046034A1 Method for identifying validated target and assay combinations
10/25/2000EP1046033A1 System and method to characterize gas transport properties
10/25/2000EP1046028A1 Immunoassay fluorometer
10/25/2000EP1046027A1 One-step fluorescent immunosensor test
10/25/2000EP1045926A2 Gene family with transformation modulating activity
10/25/2000EP1045925A1 Enzyme-specific cleavable polynucleotide substrate and assay method
10/25/2000EP1045914A1 Testis-specific human svph1-8 proteinase
10/25/2000EP1045908A2 Human urotensin ii
10/25/2000EP1045904A1 Fatty acid transport proteins
10/25/2000EP1045898A2 Compositions and methods for regulated secretion from neuroendocrine cell lines
10/25/2000EP1045860A2 Methods and compositions for treating and diagnosing insulin related disorders
10/25/2000EP1045819A1 Method for producing mass-coded combinatorial libraries
10/25/2000EP1045764A1 Labeling technique for countering product diversion and product counterfeiting
10/25/2000EP1045701A1 Methods of using human receptor protein 4-1bb
10/25/2000EP0920641B1 Method for three-dimensional and non-destructive detection of structures
10/25/2000EP0876218B1 Heating of a specimen carrier
10/25/2000EP0714418B1 Cosmetic melanins
10/25/2000EP0592549A4 Tissue specific imaging agents using internal image anti-idiotypic antibodies
10/25/2000CN1271417A Method and apparatus for rapid analysis of analytes in biological samples
10/25/2000CN1271389A Nucleic acid vaccines encoding G protein of respiratory syncytial virus
10/25/2000CN1271387A Mammalian cytokine: interleukin-B30 and related reagents
10/25/2000CN1271386A Amino-terminally trancated RANTES as chemokine antagonists
10/25/2000CN1271385A Amino-terminally truncated MCP-2 as chemokine antagnosits
10/25/2000CN1271381A Method and apparatus for separating particular matter from a liquid specimen
10/25/2000CN1271099A Integrated viral hepatitis diagnosing chip and its preparation
10/25/2000CN1271098A Integrated venereal disease diagnosing chip and its preparation
10/25/2000CN1271020A Effective test HIV-1 and HIV-2 oligonucleotide reverse transcirpt initiator and its using method
10/25/2000CN1057837C Method for judge of existence of nodularizer or CV agent in cast iron solution
10/25/2000CN1057797C Method for quantitative determination of specificity of gene amplification product by solid-phae hybridization enzyme color development reaction
10/25/2000CN1057774C 乙型肝炎疫苗 Hepatitis B Vaccine
10/24/2000US6138077 Method, apparatus and computer program product for determining a set of non-hybridizing oligonucleotides
10/24/2000US6137897 Image filing system
10/24/2000US6137708 Method for forming multi-chip sensing device and device formed
10/24/2000US6137583 Method of measuring the degree of alloying of a galvanized steel sheet using laser beams
10/24/2000US6137581 Measurement apparatus for measuring internal quality of object
10/24/2000US6137294 Prediction of bulk density of particulates with a correlation based on moisture content
10/24/2000US6136962 Covalent attachment of unmodified nucleic acids to silanized solid phase surfaces
10/24/2000US6136960 Method for evaluation of the ratio of amounts of biomolecules or their sub-populations in a mixture
10/24/2000US6136957 Antibodies which bind granulocyte-macrophane colony-stimulating factor receptor
10/24/2000US6136801 Analyzing and marking urine in patients
10/24/2000US6136786 Analgesics produced by opiates from omega-conopeptides
10/24/2000US6136612 That can be excited using inexpensive light emitting diodes and diode lasers, exhibit good water solubility, and can be conjugated to a wide variety of molecules or surfaces for labeling purposes; use in immunoassay, dna probes
10/24/2000US6136610 Device for the accurate quantitative evaluation of substances in a sample
10/24/2000US6136608 Method for determining formaldehyde present in air
10/24/2000US6136607 Multi-analyte reference solutions with stable pO2 in zero headspace containers
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136557 Strepococcus pneumoniae gene sequence FtsH
10/24/2000US6136553 Computer based method for identifying amino acid sites which affect stability of the target protein
10/24/2000US6136551 Assay for detecting the presence of botulinum toxin neutralizing antibodies in a patient serum sample
10/24/2000US6136550 Dna which encodes the amino acid sequence of an alpha5 receptor; for drug screening of agonists and antagonists
10/24/2000US6136549 systems and methods for performing magnetic chromatography assays
10/24/2000US6136548 Mutating one or more amino acids of tissue plasminogen activator, then measuring binding of mutant to beta amyloid peptide and to fibrin; improved mutant binds fibrin but does not bind beta-amyloid peptide; for alzheimer's patients
10/24/2000US6136546 Separating muscle tissue sample based on molecular weight, transferring proteins to solid support, staining for c-terminal domain; positive staining and reduced molecular weight of laminin-2 alpha 2 polypeptide indicates dystrophy
10/24/2000US6136545 Homogeneous detection methods for the determination of subpopulations of an analyte
10/24/2000US6136544 Amino acid sequence of unedited form of human excitatory amino acid 4 receptor subunit; for drug screening
10/24/2000US6136528 Multiple sclerosis virus
10/24/2000US6136527 Polypeptides derived from proteins of the hepatitis C virus, test kits containing these polypeptides and vaccines against infections of hepatitis C viruses
10/24/2000US6136526 Use of human neutrophil lipocalin (HNL) as a diagnostic marker and anti-HNL-antibody preparation
10/24/2000US6136315 Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases
10/24/2000US6136312 Method for producing an IgM preparation for intravenous application
10/24/2000US6136311 Using monoclonal antibodies
10/24/2000US6136309 Antibodies against the interferon (IFN) α/β receptor (IFNAR2) that preferentially block the activity of IFN-α
10/24/2000US6136275 Seals for containers, sockets, supports and environment surfaces
10/24/2000US6136274 Matrices with memories in automated drug discovery and units therefor
10/24/2000US6136271 Solid state apparatus employing hall effect sensors for detecting the coagulation of blood
10/24/2000US6136268 Quantification of luminescent compounds from electrolytes and electrodes
10/24/2000US6136233 For electrochemiluminescence (ecl)-based assay used in quantitation of classical clinical chemistry analytes, detecting, analyzing and monitoring analytes
10/24/2000US6136170 Exhaust gas sensor and system thereof
10/24/2000US6134952 Dissolved solid analyzer
10/24/2000US6134942 System for sampling specific pollutants contained in diluted exhaust gases from thermal engines
10/24/2000US6134941 Method of testing sensors and apparatus therefor
10/24/2000CA2257168C Apparatus for measuring heights in dissolution testing
10/24/2000CA2185535C A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
1 ... 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 ... 3937